January 20, 2023 IntegriChain Appoints Josh Halpern Chief Executive Officer IntegriChain names Joshua Halpern, co-founder and current President and Chief Operating Officer, as new Chief Executive Officer effective February 1, 2023. Kevin Leininger, current CEO, will transition to the role of Executive Chairman and remain active in the business strategy.
November 29, 2022 IntegriChain Distribution Experts to Speak at Informa Trade & Channel Strategies IntegriChain Vice President of Industry Solutions David Weiss will speak and Bill Roth, General Manager and Managing Partner, Blue Fin Group, an IntegriChain Company, will be the keynote speaker at Informa Trade & Channel Strategies.
November 17, 2022 IntegriChain Partners with PurpleLab to Enhance Pharmaceutical Channel Data for More Accurate GTN Forecasting and Accruals IntegriChain will incorporate PurpleLab prescription drug claims data to address challenges in visibility to demand and inventory that has resulted from evolving pharmaceutical channels for new specialty pharmaceutical products.
November 7, 2022 IntegriChain GTN Experts to Speak at Informa’s Pharma | BioTech GTN Summit IntegriChain is a sponsor of the hybrid conference, which runs November 15 to 17 in Philadelphia. Jen Sharpe, Jeff Baab, and Corne Smal will present 3 sessions on the Inflation Reduction Act, Commercial Launch and GTN materiality.
October 25, 2022 IntegriChain Presents Annual Customer Awards to Cytokinetics, Sebela, Boehringer Ingelheim, and Alkermes We presented our annual customer awards to innovators and visionaries in market access and commercialization. The company awards included Market Access Visionary Award to Cytokinetics, Lighthouse Award for Innovation to Sebela Pharmaceuticals, and the Patient and Channel Data Trailblazer to Boehringer Ingelheim. An individual award, the ICyte Power User Award, was presented to Jim Delaney, Senior Director, National Channel Accounts at Alkermes.
October 17, 2022 Access Insights Conference 2022 Breaks In-Person Attendance Records Access Insights Conference 2022, now co-hosted by Blue Fin Group, broke in-person attendance records. The conference opens today at the Marriott Baltimore Waterfront.
October 3, 2022 IntegriChain Medicaid Pricing Experts to Speak at MDRP Two Contracts & Pricing experts will present at Informa’s upcoming Medicaid Drug Rebate Program (MDRP) conference on digital pharmacy models and the value-based purchasing final rule. IntegriChain is a sponsor of the conference, which runs in person October 12 - 14, 2022.
July 6, 2022 Blue Fin Group Presents Market Research Study on Current and Future Payer Management in Oncology Blue Fin Group today announced a new market research study video assessing current and future payer management in oncology including influences on payer decision-making to prefer drugs in oncology, top barriers and influencers to manage oncolytics, and oncology management expectations in the next three years, including increasing contracting for preference and value-based contracting.
June 23, 2022 Blue Fin Group Releases Explanatory Video on Impacts and Future of Public Health Service 340B Program Blue Fin Group announced the availability of an in-depth video by Principal Consultant Timothy Paine that explores the Public Health Service 340B program, its evolution over 30 years, and what is expected in the coming decade.
